deltatrials
Completed NA INTERVENTIONAL 2-arm NCT05157061

GOS to Reduce Symptom Severity in IBS (EGIS)

A Multi-centre, Randomized, Placebo-Controlled, Efficacy Study of Prebiotic Galacto-oligosaccharides on Gastrointestinal Symptom Severity in Patients With Irritable Bowel Syndrome

Sponsor: CR2O B.V.

Conditions Irritable Bowel Syndrome Irritable Bowel Syndrome - Constipation Irritable Bowel Syndrome - Diarrhoea Irritable Bowel Syndrome - Mixed
Interventions Galacto-oligosaccharides (GOS) Maltodextrine
Updated 8 times since 2022 Last updated: Oct 17, 2024 Started: Oct 26, 2021 Primary completion: Aug 6, 2024 Completion: Aug 6, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Irritable Bowel Syndrome and Irritable Bowel Syndrome - Constipation, this trial is completed. The trial is conducted by CR2O B.V. and has accumulated 8 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshotRecruiting~Feb 2022 – ~Mar 2023 · 13 months · monthly snapshotRecruiting~Mar 2023 – ~Jun 2023 · 3 months · monthly snapshotRecruiting~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshotRecruiting~Nov 2024 – ~Sep 2025 · 10 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Nov 2024 — Sep 2025 [monthly]

    Completed NA

    Status: Recruiting → Completed

  3. Sep 2024 — Nov 2024 [monthly]

    Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  5. Jun 2023 — Jul 2024 [monthly]

    Recruiting NA

▶ Show 3 earlier versions

  1. Mar 2023 — Jun 2023 [monthly]

    Recruiting NA

  2. Feb 2022 — Mar 2023 [monthly]

    Recruiting NA

    Phase: PHASE3 → NA

  3. Jan 2022 — Feb 2022 [monthly]

    Recruiting PHASE3

    First recorded

Oct 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CR2O B.V.
  • Clasado
Data source: Clasado

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations